Sandoz Canada is led by a diverse team with extensive experience in the pharmaceutical industry.
Michel Robidoux has been President and General Manager of Sandoz Canada since 2010. He has over 30 years of experience in the pharmaceutical and medical equipment industries.
Under his leadership, Sandoz Canada has grown to become one of the largest pharmaceutical companies in the country with more than 60 million prescriptions per year of generic and biosimilar products. Sandoz is among the Top 35 Employers in Montreal and among the Great Place to Work companies in the country.
Mr. Robidoux began his sales and marketing career at Bayer Canada for more than seven years and then held senior positions at Roche in the Diabetes Care, Clinical Diagnostics and Applied Science Divisions.
He is an active contributor to the Canadian pharmaceutical industry as a member of the Canadian Generic Pharmaceutical Association (CGPA), Chair of Biosimilar Canada and a member of the Board of Directors of the Canadian Association of Pharmaceutical Supply Management (CAPDM).
Mr. Robidoux holds a Bachelor degree in Business Administration from the Université du Québec in Montreal and has an A.S.C. (certified company administrator) designation from the Collège des administrateurs de sociétés of Université Laval.
Ronnie Yun Shao Taormina has been Director, Innovation & Digital and a member of the Sandoz Canada Executive Committee since June 15, 2020. Before joining the team, Ronnie has accumulated more than 13 years of experience in the pharmaceutical industry, including eight years at Merck and five years at Sandoz US, where she evolved as director on several teams. Her mandate at Sandoz Canada consists of managing the strategic plan, developing the Bio-Generic business approach, managing the business relationship and activities with some partners, in addition to leading other strategic projects and the digital transformation.
Ronnie holds a Bachelor of Science and Chemical Engineering from University of California, Berkeley and a finance and marketing MBA from New York University Leonard N. Stern School of Business.
Martin Arès has more than 25 years of experience working for global pharmaceutical companies in Canada and Europe. While his career started in sales, he quickly progressed to senior marketing positions, then to global roles, and subsequently to senior management roles in Europe. Since his return to Montreal in 2012, Mr. Arès has held leadership positions at Bristol Myers Squibb and at Sanofi, where he was Vice President, Diabetes and Cardiovascular.
Mr. Arès is recognized as a passionate leader and a strategic thinker with skills in business development, building strong vision, team leadership and talent development. His success stems from his excellent knowledge of the market, his thorough understanding of customer needs and market trends, and his ability to make the right choices to ensure the company's growth. He attracts strong talents and, through his collaborative style, he mobilizes teams to meet clear yet ambitious common objectives.
Under his leadership, Sandoz Canada was named best generics company and best partner in 2017, 2018 and 2019 by one of the largest retailer and wholesaler in Canada. Mr. Arès has been instrumental in advancing Sandoz Canada's market share to the coveted number two position in the Canadian generic pharmaceutical industry. He has been a key player in Sandoz Canada’s evolution into a unique Bio-Generic company and manages one of the largest product portfolios in the industry.
Mr. Arès holds a bachelor's degree in finance and marketing from HEC in Montreal and studied in the fields of strategy and leadership at the London Business School of Economics.
Jocelyn Binet has been Executive Director, Integrity and Compliance, Commercial Operations, since January 2018. Before joining Sandoz in 2017, he was Director of Inquiries and Syndic at the Ordre des pharmaciens du Québec. He also worked as a legal director, corporate secretary and legal consultant at Eli Lilly Canada.
Mr. Binet holds degrees in pharmacy and law
Mark Boehmer is Vice President Business Development, Portfolio & Launch Management since February 2017. He has worked in our industry for more than 25 years and is a pharmacist with hospital and community experience. He was most recently (since 2011) Vice President, Pharmaceutical Procurement, at the Katz Group, where he was responsible for managing the generic program for Rexall Pharmacy and gained a vast experience with Canadian pharmaceutical products.
Prior to Katz, M. Boehmer worked for several well-known pharmaceutical companies, including Merck Frosst Canada, Eli Lilly Canada and Schering Canada, before joining Patheon Inc. as Senior Manager, Pharmaceutical Development Services, in 1996. Over the following 15 years, he held increasingly senior positions with this leading global provider of outsourced drug development and manufacturing.
He holds a BSc (Chemistry) and Bachelor of Pharmacy from the University of Manitoba and an MBA from McMaster University, Michael G. DeGroote School of Business.
Martin Fournier has been Vice-President Finance and CFO since 2015. He is also in charge of business to business relations for Sandoz Canada since 2019. He joined Sandoz in 2006 as Director, Information and Financial Accounting. He has over 17 years of diverse project management experience in the field of accounting and finance, mainly within businesses in the manufacturing sector. Before joining Sandoz, he held various positions in accounting firms at the auditing and consulting levels, most recently at Deloitte as Senior Director, Management and Technology Consulting.
Mr. Fournier holds a Bachelor’s degree in Accounting, B.B.A., from Hautes Études Commerciales Montréal. He is also a member of the Ordre des comptables agréés du Québec.
Mauricio Ede is the Chief Medical & Scientific Officer and has been working for Sandoz Canada since February 2019. Cardiovascular surgeon and PhD in Physiology, Mauricio has more than 20 years of experience in health care in Canada and the United States. He has led scientific and regulatory teams in several pharmaceutical companies, including Merck Canada, Baxter and Abbott. He has lent his medical expertise and leadership to numerous product launches approved by regulatory authorities, including Health Canada, as well as to successful reimbursement efforts in Canadian provinces. He has also authored numerous scientific publications, mainly in the field of cardiovascular surgery.
Marc Boisvert has been Vice President, Supply Chain since April 2020, ensuring the demand management, the supply, the distribution and customer service, among other things. It is the second time Mr. Boisvert takes on this role by interim as a replacement of his colleague in maternity leave. In 2019, Mr. Boisvert acted as US Supply Operations Head at Sandoz US during a 14-month assignment. This enriching experience adds up to his extensive knowledge of internal and external global partners, which he has accumulated over 17 years at Sandoz in many leadership roles.
Mr. Boisvert holds an executive MBA from Université du Québec à Montréal, a Graduate Diploma in International Administration from École nationale d’administration publique and a Bachelor’s in Operations Management and International Management from HEC Montréal.
Karine Matteau leads the Biosimilar business segment and the growth of Sandoz’ portfolio of biosimilar products in various therapeutic fields. Ms. Matteau has over 20 years of experience in the pharmaceutical industry in various commercial strategic roles. She joined Novartis in 2007 and in the last 11 years, she has had a successful path through various commercial roles in multiple general medicine and specialty divisions. In her last mandates, she assumed leadership positions in Sales & Marketing within the Novartis Oncology division. Prior to Novartis, she held various commercial positions at Sanofi-Aventis Canada, mainly in CV & Metabolism/Diabetes.
Karine Matteau’s academic background includes an MBA from HEC Montreal and a Bachelor of Science from McGill University.
Isabelle Robitaille has been Vice President, Legal Affairs and General Counsel since January 2019.
Ms. Robitaille joined Sandoz in 2014 and is an expert in the fields of business and commercial law, mergers and acquisitions, and intellectual property rights.
She holds a Bachelor of Law from the Université de Sherbrooke and has 20 years of experience in transactional law, including more than 15 years in the pharmaceutical industry.
Marc St-Pierre holds the position of Vice President, People & Organization. His main responsibilities are to oversee the design and implementation of innovative programs focused on energy, development and job satisfaction in order to attract and retain the best talent, while ensuring policy alignment. He also leads the Communications team, which develops and implements communications plans intended for internal and external audiences in order to promote the reputation of Sandoz as a choice employer and industry leader in Canada.
Having joined Sandoz (previously Sabex) in 1997, Mr. St-Pierre has over 25 years' experience in the field of human resources management. He has previously held several management positions in industry-leading companies, more specifically in the publishing/direct mail business (with Reader's Digest) as well as telecommunications (with Canadian Marconi Company).
Mr. St-Pierre holds a Bachelor's degree in Industrial Relations from the Université du Québec en Outaouais and is a member of the Ordre des conseillers en ressources humaines agréés (CHRP).
Visit LinkedIn profile